Solvias Achieves Recognized Sustainability Milestone
In a significant achievement for the global provider of chemistry, manufacturing, and controls (CMC) services, Solvias has proudly announced its receipt of the Bronze Medal from EcoVadis. This prestigious recognition places Solvias among the top 35% of over 100,000 companies evaluated for sustainability performance worldwide.
Highlighting Progress in Sustainability
EcoVadis is respected globally for its evaluations of sustainable business practices, focusing on four key areas: environmental management, labor and human rights, ethics, and sustainable procurement. The Bronze Medal awarded to Solvias reflects the company’s ongoing commitment to enhancing responsible business practices across its operations and the entire supply chain.
This milestone builds on an earlier EcoVadis assessment where Solvias received a 'Committed' badge in 2025, marking the official start of its comparative evaluation journey in sustainability.
Integrating ESG into Global Operations
Since initiating its ESG (Environmental, Social, Governance) strategy in 2024, Solvias has adopted a robust sustainability framework that strives for measurable improvements across all global operations and its supply chain. Key initiatives include:
- - Calculating the company's carbon footprint (Scopes 1-3)
- - Setting ambitious sustainability goals
- - Implementing a comprehensive five-year ESG roadmap
- - Strengthening governance, ethical business practices, and sustainable procurement standards
According to Archie Cullen, CEO of Solvias, “The attainment of the EcoVadis Bronze Medal signifies the substantial progress made by our teams in embedding sustainability into our operations and business practices. This recognition underlines our commitment to continuous improvement as we assist our partners in responsibly advancing life-changing therapies.”
Advancing Sustainable Practices in Life Sciences
Solvias, as a partner to pharmaceutical, biotechnology, and life sciences sectors, is dedicated to enhancing initiatives that minimize environmental impact while fostering responsible business practices.
The company’s long-term sustainability strategy entails a deeper alignment with internationally recognized frameworks, such as the Science Based Targets initiative (SBTi), alongside continuous enhancements in ESG transparency.
By integrating sustainability into its operational and strategic priorities, Solvias aims to support innovation in drug development and contribute to more sustainable supply chains in healthcare and life sciences.
About Solvias
Headquartered near Basel, Switzerland, Solvias is a leading global provider of analytical and regulatory services for chemistry, manufacturing, and controls (CMC) tailored for the life sciences industry. Their expert teams support pharmaceutical and biotechnology companies working with small molecules, biologics, and novel modalities, delivering analytical solutions from raw material testing to official pharmaceutical release.
For more information about Solvias and its commitment to sustainability, visit
www.solvias.com.